10-Q Filing

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. CIK: 1350156 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001262463-22-000015`
Period End Date	20211130
Filing Date	20220114
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	paxh113021q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 40 Cash Flow Statement 36 Stockholders Equity 16

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.00	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.77M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$40.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$46.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$40.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$110.00	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.77M	shares	Point-in-time
Total assets	`Assets`	$110.00	USD	Point-in-time
Total assets	`Assets`	$40.00	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$163.03K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$159.14K	USD	Point-in-time
Accounts payable and accrued liabilities - related party	`AccountsPayableRelatedPartiesCurrent`	$429.12K	USD	Point-in-time
Accounts payable and accrued liabilities - related party	`AccountsPayableRelatedPartiesCurrent`	$489.12K	USD	Point-in-time
Advances - related party	`DueToRelatedPartiesCurrent`	$54.97K	USD	Point-in-time
Advances - related party	`DueToRelatedPartiesCurrent`	$37.70K	USD	Point-in-time
Loans payable - shareholders	`LoansPayableCurrent`	$148.33K	USD	Point-in-time
Loans payable - shareholders	`LoansPayableCurrent`	$136.47K	USD	Point-in-time
Liability for unissued shares	`OtherLiabilitiesCurrent`	$134.79K	USD	Point-in-time
Liability for unissued shares	`OtherLiabilitiesCurrent`	$134.79K	USD	Point-in-time
Convertible note payable - related party	`ConvertibleNotesPayableCurrent`	$1.06M	USD	Point-in-time
Convertible note payable - related party	`ConvertibleNotesPayableCurrent`	$1.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.05M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.96M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.96M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.05M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, 75,000,000 shares authorized 19,767,698 shares issued and outstanding	`CommonStockValue`	$19.77K	USD	Point-in-time
Common Stock, $0.001 par value, 75,000,000 shares authorized 19,767,698 shares issued and outstanding	`CommonStockValue`	$19.77K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.66M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.20K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.20K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.78M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-2.00M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.96M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.88M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.83M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$110.00	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$40.00	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	$230.00	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	$271.00	USD	2 Qtrs
Consulting	`ConsultingFees`	$30.79K	USD	1 Quarter
Consulting	`ConsultingFees`	$60.00K	USD	2 Qtrs
Consulting	`ConsultingFees`	$30.00K	USD	1 Quarter
Consulting	`ConsultingFees`	$60.78K	USD	2 Qtrs
Professional	`ProfessionalFees`	$11.82K	USD	2 Qtrs
Professional	`ProfessionalFees`	$3.51K	USD	1 Quarter
Professional	`ProfessionalFees`	$11.82K	USD	1 Quarter
Professional	`ProfessionalFees`	$11.38K	USD	2 Qtrs
Office and administration	`GeneralAndAdministrativeExpense`	$7.01K	USD	2 Qtrs
Office and administration	`GeneralAndAdministrativeExpense`	$7.52K	USD	1 Quarter
Office and administration	`GeneralAndAdministrativeExpense`	$3.51K	USD	1 Quarter
Office and administration	`GeneralAndAdministrativeExpense`	$9.14K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.07K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.07K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.15K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.42K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$85.46K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$47.40K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$43.88K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$82.25K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-47.40K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-85.19K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-82.25K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-43.66K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-82.25K	USD	2 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-47.40K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-85.19K	USD	2 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-43.66K	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.77M	shares	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.77M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.77M	shares	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.77M	shares	1 Quarter

Cash Flow Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-82.25K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.40K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-85.19K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.66K	USD	1 Quarter
Increase in accounts payable and accrued liabilities - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$60.00K	USD	2 Qtrs
Increase in accounts payable and accrued liabilities - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$60.00K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.88K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.45K	USD	2 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-29.07K	USD	2 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.81K	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Bank indebtedness	`BankIndebtedness`	$42.00	USD	2 Qtrs
Bank indebtedness	`BankIndebtedness`	-	USD	2 Qtrs
Advances - loans payable - shareholders	`ProceedsFromLoans`	$11.87K	USD	2 Qtrs
Advances - loans payable - shareholders	`ProceedsFromLoans`	-	USD	2 Qtrs
Advances - related party	`ProceedsFromRelatedPartyDebt`	$17.48K	USD	2 Qtrs
Advances - related party	`ProceedsFromRelatedPartyDebt`	$20.54K	USD	2 Qtrs
Repayment of advances - related party	`RepaymentsOfRelatedPartyDebt`	$826.00	USD	2 Qtrs
Repayment of advances - related party	`RepaymentsOfRelatedPartyDebt`	$210.00	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.14K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.76K	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$70.00	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-46.00	USD	2 Qtrs
Cash, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$110.00	USD	Point-in-time
Cash, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$40.00	USD	Point-in-time
Cash, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.00	USD	Point-in-time
Cash, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$110.00	USD	Point-in-time
Cash, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$40.00	USD	Point-in-time
Cash, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.00	USD	Point-in-time
Cash, end of the period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$-2.00M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.96M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.83M	USD	Point-in-time
Net loss and comprehensive loss	`NetIncomeLoss`	$-82.25K	USD	2 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-47.40K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-85.19K	USD	2 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-43.66K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$-2.00M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.96M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.